Alfirevic A - Search Results

1

ABCB1 single nucleotide polymorphisms (1236C>T, 2677G>T, and 3435C>T) do not affect transport activity of human P-glycoprotein.

Dickens D, Owen A, Alfirevic A, Pirmohamed M. Dickens D, et al. Among authors: alfirevic a. Pharmacogenet Genomics. 2013 Jun;23(6):314-23. doi: 10.1097/FPC.0b013e328360d10c. Pharmacogenet Genomics. 2013. PMID: 23619510

2

Association analysis of drug metabolizing enzyme gene polymorphisms in HIV-positive patients with co-trimoxazole hypersensitivity.

Pirmohamed M, Alfirevic A, Vilar J, Stalford A, Wilkins EG, Sim E, Park BK. Pirmohamed M, et al. Among authors: alfirevic a. Pharmacogenetics. 2000 Nov;10(8):705-13. doi: 10.1097/00008571-200011000-00005. Pharmacogenetics. 2000. PMID: 11186133

3

Cost-effectiveness analysis of HLA B*5701 genotyping in preventing abacavir hypersensitivity.

Hughes DA, Vilar FJ, Ward CC, Alfirevic A, Park BK, Pirmohamed M. Hughes DA, et al. Among authors: alfirevic a. Pharmacogenetics. 2004 Jun;14(6):335-42. doi: 10.1097/00008571-200406000-00002. Pharmacogenetics. 2004. PMID: 15247625

4

Serious carbamazepine-induced hypersensitivity reactions associated with the HSP70 gene cluster.

Alfirevic A, Mills T, Harrington P, Pinel T, Sherwood J, Jawaid A, Smith JC, March RE, Barratt BJ, Chadwick DW, Kevin Park B, Pirmohamed M. Alfirevic A, et al. Pharmacogenet Genomics. 2006 Apr;16(4):287-96. doi: 10.1097/01.fpc.0000189800.88596.7a. Pharmacogenet Genomics. 2006. PMID: 16538175

5

Tacrine-induced liver damage: an analysis of 19 candidate genes.

Alfirevic A, Mills T, Carr D, Barratt BJ, Jawaid A, Sherwood J, Smith JC, Tugwood J, Hartkoorn R, Owen A, Park KB, Pirmohamed M. Alfirevic A, et al. Pharmacogenet Genomics. 2007 Dec;17(12):1091-100. doi: 10.1097/FPC.0b013e3282f1f12b. Pharmacogenet Genomics. 2007. PMID: 18004213

6

Molecular and genetic association of interleukin-6 in tacrine-induced hepatotoxicity.

Carr DF, Alfirevic A, Tugwood JD, Barratt BJ, Sherwood J, Smith J, Pirmohamed M, Park BK. Carr DF, et al. Among authors: alfirevic a. Pharmacogenet Genomics. 2007 Nov;17(11):961-72. doi: 10.1097/FPC.0b013e3282f00919. Pharmacogenet Genomics. 2007. PMID: 18075466

7

Investigation of inter-individual variability of the one-carbon folate pathway: a bioinformatic and genetic review.

Carr DF, Whiteley G, Alfirevic A, Pirmohamed M; FolATED study team. Carr DF, et al. Among authors: alfirevic a. Pharmacogenomics J. 2009 Oct;9(5):291-305. doi: 10.1038/tpj.2009.29. Epub 2009 Jul 7. Pharmacogenomics J. 2009. PMID: 19581920 Review.

8

Effects of CYP4F2 genetic polymorphisms and haplotypes on clinical outcomes in patients initiated on warfarin therapy.

Zhang JE, Jorgensen AL, Alfirevic A, Williamson PR, Toh CH, Park BK, Pirmohamed M. Zhang JE, et al. Among authors: alfirevic a. Pharmacogenet Genomics. 2009 Oct;19(10):781-9. doi: 10.1097/FPC.0b013e3283311347. Pharmacogenet Genomics. 2009. PMID: 19741565

9

Metabolic acidosis with topiramate and zonisamide: an assessment of its severity and predictors.

Mirza NS, Alfirevic A, Jorgensen A, Marson AG, Pirmohamed M. Mirza NS, et al. Among authors: alfirevic a. Pharmacogenet Genomics. 2011 May;21(5):297-302. doi: 10.1097/FPC.0b013e3283441b95. Pharmacogenet Genomics. 2011. PMID: 21278619

10

Lamotrigine is a substrate for OCT1 in brain endothelial cells.

Dickens D, Owen A, Alfirevic A, Giannoudis A, Davies A, Weksler B, Romero IA, Couraud PO, Pirmohamed M. Dickens D, et al. Among authors: alfirevic a. Biochem Pharmacol. 2012 Mar 15;83(6):805-14. doi: 10.1016/j.bcp.2011.12.032. Epub 2011 Dec 29. Biochem Pharmacol. 2012. PMID: 22227272

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results